Tag: India
Max Healthcare reports strong growth in Q3
Company's gross revenue stood at INR 1160 Cr, a growth of 6% YoY and 24% QoQ.....................
Biocon Biologics to offer its oncology biosimilars in over 30 countries
The company's agreement with the Clinton Health Access Initiative (CHAI) to expand access to lifesaving cancer biosimilars will enable access to Trastuzumab and Pegfilgrastim in Africa and Asia...................
Pan-India study shows young Indians aged 18-30 years are most affected...
A pan-India study underscores that 77% of the population tested showed deficiency and the prevalence is highest in adults aged 18-30 years (81.2%)....................
Zydus completes Phase-I trials of its anti-malarial compound
Phase I healthy volunteers study demonstrated long half-life and potential for a single-dose cure for malaria. Potent antimalarial activity demonstrated in malaria challenge trial following single-dose oral administration of ZY19489.......................
#Budget2021: Health stakeholders hail 137% hike in allocation
The budget allocation of Rs 2,23,846 crore, as per experts, will help in reducing the rural-urban divide and capacity enhancement interventions across the value chain.................
COVID-19 vaccine rollout gets a mega budget outlay of Rs 35,000...
India has two vaccines available and has begun medically safeguarding not only her own citizens against COVID-19 but also those of 100 or more countries..................
COVID-19: India steadily sustains its trajectory of very low active cases
2 States alone contribute nearly 65% of the Total Active Caseload of the country. 131 Daily New Deaths registered in the last 24 hours after 8 months......................
NITI Aayog to launch 2nd edition of India Innovation Index 2020
The release of the second edition of the index—the first was launched in October 2019—demonstrates the Government’s continued commitment towards transforming the country into an innovation-driven economy.................
India’s first indigenous flow diverter stent device to be in market...
The cost of the Chitra Flow Diverter stent for correcting ballooning of brain arteries & device for the healing of the heart hole is expected to be priced significantly lower than the currently imported ones......................
Budget 2021: MTaI seeks reduction in customs duties, rollback of health...
As per the Medical Technology Association of India, the high customs duties have adversely impacted the costs of products in India which contradicts the government’s efforts to provide low-cost healthcare to the masses through ambitious schemes such as AB-PMJAY...........................